Vimarsana
Biggest News Aggregation in the World

Page 31 - Drug Controller General News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Controller General Today - Breaking & Trending Today

Epharmacy Players Meet Officials At G20 Goa, Talk Rules - Vimarsana News

Epharmacy Players Meet Officials At G20 Goa, Talk Rules

Epharmacy companies reportedly met with health ministry officials at the G20 meetings in Goa earlier this week to discuss industry rules.

Source: inc42.com
DGCI cancels license of 18 pharma firms, months after cough syrup deaths - Vimarsana News

DGCI cancels license of 18 pharma firms, months after cough syrup deaths

The decision by the DGCA was taken after it examined 76 enterprises across 20 states and union territories, with close to 203 firms being identified for review.

Indian startup develops AI-based blood test to detect 32 cancers early - Vimarsana News

Indian startup develops AI-based blood test to detect 32 cancers early

Even as detecting cancer early remains key, a Gurugram-based startup PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women, with 98 per cent accuracy.

Indian startup develops AI-based blood test to identify 32 tumours early - Vimarsana News

Indian startup develops AI-based blood test to identify 32 tumours early

Even though early cancer detection is still crucial, Gurugram-based startup PredOmix has created a cutting-edge...

Welcome To IANS Live - SCIENCE-AND-TECHNOLOGY - Indian startup develops AI-based blood test to detect 32 cancers early - Vimarsana News

Welcome To IANS Live - SCIENCE-AND-TECHNOLOGY - Indian startup develops AI-based blood test to detect 32 cancers early

The company's OncoVeryx-F is a patented technology that combines metabolomics (study of small molecules) and Artificial Intelligence (AI) to identify metabolite signatures of multiple cancers in a single test.